Xiang Y - Search Results

1

Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations.

Xie Y, Xiang Y, Sheng J, Zhang D, Yao X, Yang Y, Zhang X. Xie Y, et al. Among authors: xiang y. J Immunol Res. 2018 Mar 26;2018:8740976. doi: 10.1155/2018/8740976. eCollection 2018. J Immunol Res. 2018. PMID: 29785403 Free PMC article. Review.

2

Endoplasmic reticulum stress: Multiple regulatory roles in hepatocellular carcinoma.

Wu J, Qiao S, Xiang Y, Cui M, Yao X, Lin R, Zhang X. Wu J, et al. Among authors: xiang y. Biomed Pharmacother. 2021 Oct;142:112005. doi: 10.1016/j.biopha.2021.112005. Epub 2021 Aug 20. Biomed Pharmacother. 2021. PMID: 34426262 Free article. Review.

3

Sarcomatoid carcinoma of the pancreas: A case report and review of the literature.

Xie Y, Xiang Y, Zhang D, Yao X, Sheng J, Yang Y, Zhang X. Xie Y, et al. Among authors: xiang y. Mol Med Rep. 2018 Nov;18(5):4716-4724. doi: 10.3892/mmr.2018.9489. Epub 2018 Sep 14. Mol Med Rep. 2018. PMID: 30221744 Review.

4

Pancreatic reconstruction techniques after pancreaticoduodenectomy: a review of the literature.

Xiang Y, Wu J, Lin C, Yang Y, Zhang D, Xie Y, Yao X, Zhang X. Xiang Y, et al. Expert Rev Gastroenterol Hepatol. 2019 Aug;13(8):797-806. doi: 10.1080/17474124.2019.1640601. Epub 2019 Jul 12. Expert Rev Gastroenterol Hepatol. 2019. PMID: 31282769 Review.

5

Bioinformatic Analysis of Circular RNA-Associated ceRNA Network Associated with Hepatocellular Carcinoma.

Wu J, Liu S, Xiang Y, Qu X, Xie Y, Zhang X. Wu J, et al. Among authors: xiang y. Biomed Res Int. 2019 Nov 3;2019:8308694. doi: 10.1155/2019/8308694. eCollection 2019. Biomed Res Int. 2019. PMID: 31886256 Free PMC article.

6

MiR-23a-3p promoted G1/S cell cycle transition by targeting protocadherin17 in hepatocellular carcinoma.

Xiang Y, Yang Y, Lin C, Wu J, Zhang X. Xiang Y, et al. J Physiol Biochem. 2020 Feb;76(1):123-134. doi: 10.1007/s13105-020-00726-4. Epub 2020 Jan 28. J Physiol Biochem. 2020. PMID: 31994011

7

Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis.

Lin C, Xiang Y, Sheng J, Liu S, Cui M, Zhang X. Lin C, et al. Among authors: xiang y. J Physiol Biochem. 2020 Aug;76(3):469-481. doi: 10.1007/s13105-020-00754-0. Epub 2020 Jul 3. J Physiol Biochem. 2020. PMID: 32621257

8

Glycometabolic rearrangements--aerobic glycolysis in pancreatic cancer: causes, characteristics and clinical applications.

Cao L, Wu J, Qu X, Sheng J, Cui M, Liu S, Huang X, Xiang Y, Li B, Zhang X, Cui R. Cao L, et al. Among authors: xiang y. J Exp Clin Cancer Res. 2020 Nov 30;39(1):267. doi: 10.1186/s13046-020-01765-x. J Exp Clin Cancer Res. 2020. PMID: 33256814 Free PMC article. Review.

9

Advances in Renal Cell Carcinoma Drug Resistance Models.

Xiang Y, Zheng G, Zhong J, Sheng J, Qin H. Xiang Y, et al. Front Oncol. 2022 May 10;12:870396. doi: 10.3389/fonc.2022.870396. eCollection 2022. Front Oncol. 2022. PMID: 35619895 Free PMC article. Review.

10

Recent Advances in Herbal Medicines for Digestive System Malignancies.

Sheng J, Zou X, Cheng Z, Xiang Y, Yang W, Lin Y, Cui R. Sheng J, et al. Among authors: xiang y. Front Pharmacol. 2018 Nov 20;9:1249. doi: 10.3389/fphar.2018.01249. eCollection 2018. Front Pharmacol. 2018. PMID: 30524272 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,407 results

Search Page